HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regulatory role of c-Met in insulin-like growth factor-I receptor-mediated migration and invasion of human pancreatic carcinoma cells.

Abstract
Pancreatic carcinoma cells overexpress the insulin-like growth factor-I (IGF-I) receptor (IGF-IR) and the hepatocyte growth factor (HGF) receptor, c-Met, which are both known to mediate tumor cell migration and invasion. We hypothesized that IGF-IR and c-Met cooperate to induce migration and invasion of human pancreatic carcinoma cells and that IGF-I-mediated migration and invasion depend on c-Met. Migration and invasion assays were done with the human pancreatic cancer cell line L3.6pl treated with PBS, IGF-I, HGF, or IGF-I plus HGF. To determine if c-Met is necessary for IGF-IR-mediated migration and invasion, c-Met was down-regulated in L3.6pl cells via adenoviral infection with a c-Met ribozyme before IGF-I treatment. IGF-I and HGF increased cell migration and invasion. Furthermore, IGF-I plus HGF had a greater than additive effect on cell migration and invasion compared with either growth factor alone. Down-regulation of c-Met nearly completely inhibited IGF-I-mediated migration and invasion. Our findings suggest that IGF-IR and c-Met cooperate to induce migration and invasion of human pancreatic carcinoma cells. Furthermore, c-Met is required for both HGF- and IGF-I-mediated migration and invasion. Elucidation of the signaling pathways that contribute to tumor progression and metastasis should provide a foundation for the development of targeted therapies for pancreatic carcinoma.
AuthorsTodd W Bauer, Ray J Somcio, Fan Fan, Wenbiao Liu, Marjorie Johnson, Donald P Lesslie, Douglas B Evans, Gary E Gallick, Lee M Ellis
JournalMolecular cancer therapeutics (Mol Cancer Ther) Vol. 5 Issue 7 Pg. 1676-82 (Jul 2006) ISSN: 1535-7163 [Print] United States
PMID16891453 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Hepatocyte Growth Factor
  • Insulin-Like Growth Factor I
  • Proto-Oncogene Proteins c-met
  • Receptor, IGF Type 1
Topics
  • Carcinoma (metabolism, pathology)
  • Cell Movement (drug effects)
  • Hepatocyte Growth Factor (pharmacology)
  • Humans
  • Insulin-Like Growth Factor I (pharmacology)
  • Neoplasm Invasiveness
  • Pancreatic Neoplasms (metabolism, pathology)
  • Phosphorylation
  • Proto-Oncogene Proteins c-met (antagonists & inhibitors, metabolism)
  • Receptor, IGF Type 1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: